An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study
- PMID: 25242015
- PMCID: PMC4194358
- DOI: 10.1186/1471-2458-14-986
An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study
Abstract
Background: An effective HIV vaccine is still elusive. Of the 9 HIV preventive vaccine efficacy trials conducted to-date, only one reported positive results of modest efficacy. More efficacy trials need to be conducted before one or more vaccines are eventually licensed. We assessed the suitability of fishing communities in Uganda for future HIV vaccine efficacy trials.
Methods: A community-based cohort study was conducted among a random sample of 2191 participants aged 18-49 years. Data were collected on socio-demographic characteristics, HIV risky behaviors, and willingness to participate in future HIV vaccine trials (WTP). Venous blood was collected for HIV serological testing. Retention/follow rates and HIV incidence rates per 100 person years at-risk (pyar) were estimated. Adjusted prevalence proportion ratios (PPRs) of retention and odds ratios (ORs) of lack of WTP were estimated using log-binomial and logistic regression models respectively.
Results: Overall retention rate was 76.9% (1685/2191), highest (89%) among participants who had spent 5+ years in the community and lowest (54.1%) among those with <1 year stay. Significant predictors of retention included tribe/ethnicity, baseline HIV negative status, and longer than 1 year stay in the community. Overall WTP was 89.1% (1953/2191). Lack of WTP was significantly higher among women than men [adj.OR = 1.51 (95% CI, 1.14- 2.00)] and among participants who had stayed in fishing communities for 10 or more years relative to those with less than one year [adj.OR = 1.78 (95% CI, 1.11 - 2.88)]. Overall HIV incidence rate per 100 pyar was 3.39 (95% CI; 2.55 - 4.49). Participants aged 25-29 years had highest incidence rates (4.61 - 7.67/100 pyar) and high retention rates between 78.5 and 83.1%. In a combined analysis of retention and incidence rates participants aged 30+ years had retention rates ~80% but low incidence rates (2.45 - 3.57 per 100 pyar) while those aged 25-29 years had the highest incidence rates (4.61 - 7.67/100 pyar) and retention rates 78.5 - 83.1%.
Conclusions: There is high HIV incidence, retention and WTP among fishing communities around L. Victoria, Uganda which make these communities appropriate for future HIV prevention efficacy studies including vaccine trials.
Similar articles
-
High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.J Int AIDS Soc. 2013 Jul 22;16(1):18621. doi: 10.7448/IAS.16.1.18621. J Int AIDS Soc. 2013. PMID: 23880102 Free PMC article.
-
High incidence of HIV-1 infection in a general population of fishing communities around Lake Victoria, Uganda.PLoS One. 2014 May 27;9(5):e94932. doi: 10.1371/journal.pone.0094932. eCollection 2014. PLoS One. 2014. PMID: 24866840 Free PMC article. Clinical Trial.
-
Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.Vaccine. 2013 Oct 17;31(44):5055-61. doi: 10.1016/j.vaccine.2013.08.080. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24021306 Free PMC article.
-
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda.Int J Environ Res Public Health. 2022 May 24;19(11):6377. doi: 10.3390/ijerph19116377. Int J Environ Res Public Health. 2022. PMID: 35681962 Free PMC article. Review.
-
Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.Hum Vaccin Immunother. 2014;10(7):1974-84. doi: 10.4161/hv.28870. Hum Vaccin Immunother. 2014. PMID: 25424807 Free PMC article. Review.
Cited by
-
Use of propensity score matching to create counterfactual group to assess potential HIV prevention interventions.Sci Rep. 2021 Mar 29;11(1):7017. doi: 10.1038/s41598-021-86539-x. Sci Rep. 2021. PMID: 33782485 Free PMC article.
-
Barriers and Facilitators of Family Planning Use in Fishing Communities of Lake Victoria in Uganda.J Prim Care Community Health. 2020 Jan-Dec;11:2150132720943775. doi: 10.1177/2150132720943775. J Prim Care Community Health. 2020. PMID: 32698653 Free PMC article.
-
Livelihood Risk, Culture, and the HIV Interface: Evidence from Lakeshore Border Communities in Buliisa District, Uganda.J Trop Med. 2019 May 16;2019:6496240. doi: 10.1155/2019/6496240. eCollection 2019. J Trop Med. 2019. PMID: 31223313 Free PMC article.
-
Comparison of retention in observational cohorts and nested simulated HIV vaccine efficacy trials in the key populations in Uganda.BMC Med Res Methodol. 2020 Feb 12;20(1):32. doi: 10.1186/s12874-020-00920-4. BMC Med Res Methodol. 2020. PMID: 32050900 Free PMC article.
-
Adherence to a Vaccination Schedule in a Simulated HIV Vaccine Efficacy Trial Among Adults in Fishing Communities Around Lake Victoria, Uganda.Vaccines (Basel). 2025 May 13;13(5):515. doi: 10.3390/vaccines13050515. Vaccines (Basel). 2025. PMID: 40432123 Free PMC article.
References
-
- Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–666. doi: 10.1016/S0140-6736(07)60313-4. - DOI - PubMed
-
- Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410. doi: 10.1056/NEJMoa1108524. - DOI - PMC - PubMed
-
- Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–434. doi: 10.1056/NEJMoa1110711. - DOI - PubMed
Pre-publication history
-
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/14/986/prepub
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical